Cargando…

“Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa

Trust is a key element of high-quality stakeholder relations, which are themselves essential for the success of HIV vaccine trials. Where trust is absent, community stakeholders might not volunteer to become involved in key trial activities, and potential participants might not volunteer for enrollm...

Descripción completa

Detalles Bibliográficos
Autores principales: Thabethe, Siyabonga, Slack, Catherine, Lindegger, Graham, Wilkinson, Abigail, Wassenaar, Douglas, Kerr, Philippa, Bekker, Linda-Gail, Mngadi, Kathy, Newman, Peter A.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2018
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238163/
https://www.ncbi.nlm.nih.gov/pubmed/30417754
http://dx.doi.org/10.1177/1556264618804740
_version_ 1783371319175282688
author Thabethe, Siyabonga
Slack, Catherine
Lindegger, Graham
Wilkinson, Abigail
Wassenaar, Douglas
Kerr, Philippa
Bekker, Linda-Gail
Mngadi, Kathy
Newman, Peter A.
author_facet Thabethe, Siyabonga
Slack, Catherine
Lindegger, Graham
Wilkinson, Abigail
Wassenaar, Douglas
Kerr, Philippa
Bekker, Linda-Gail
Mngadi, Kathy
Newman, Peter A.
author_sort Thabethe, Siyabonga
collection PubMed
description Trust is a key element of high-quality stakeholder relations, which are themselves essential for the success of HIV vaccine trials. Where trust is absent, community stakeholders might not volunteer to become involved in key trial activities, and potential participants might not volunteer for enrollment. We explored site staff and Community Advisory Board (CAB) members’ experiences of trust/mistrust among community members and potential participants. We analyzed 10 focus group discussions with site staff and CAB members at two active South African HIV vaccine trial sites. We report on key characteristics perceived to contribute to the trustworthiness of communicators, as well as factors associated with mistrust. Attributes associated with trustworthy communicators included shared racial identity, competence, and independence (not being “captured”). Key foci for mistrust included explanations about site selection, stored samples, vaccination, and Vaccine Induced Sero-Positivity (VISP). Our findings suggest that community members’ trust is not necessarily global, in which trials are trusted or not; rather, it appears fairly nuanced and is impacted by various perceived attributes of communicators and the information they provide. We make recommendations for clinical trial site stakeholders invested in building trust and for future research into trust at these sites.
format Online
Article
Text
id pubmed-6238163
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-62381632018-12-10 “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa Thabethe, Siyabonga Slack, Catherine Lindegger, Graham Wilkinson, Abigail Wassenaar, Douglas Kerr, Philippa Bekker, Linda-Gail Mngadi, Kathy Newman, Peter A. J Empir Res Hum Res Ethics Research Risks, Benefits and Trust Trust is a key element of high-quality stakeholder relations, which are themselves essential for the success of HIV vaccine trials. Where trust is absent, community stakeholders might not volunteer to become involved in key trial activities, and potential participants might not volunteer for enrollment. We explored site staff and Community Advisory Board (CAB) members’ experiences of trust/mistrust among community members and potential participants. We analyzed 10 focus group discussions with site staff and CAB members at two active South African HIV vaccine trial sites. We report on key characteristics perceived to contribute to the trustworthiness of communicators, as well as factors associated with mistrust. Attributes associated with trustworthy communicators included shared racial identity, competence, and independence (not being “captured”). Key foci for mistrust included explanations about site selection, stored samples, vaccination, and Vaccine Induced Sero-Positivity (VISP). Our findings suggest that community members’ trust is not necessarily global, in which trials are trusted or not; rather, it appears fairly nuanced and is impacted by various perceived attributes of communicators and the information they provide. We make recommendations for clinical trial site stakeholders invested in building trust and for future research into trust at these sites. SAGE Publications 2018-11-12 2018-12 /pmc/articles/PMC6238163/ /pubmed/30417754 http://dx.doi.org/10.1177/1556264618804740 Text en © The Author(s) 2018 http://creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Research Risks, Benefits and Trust
Thabethe, Siyabonga
Slack, Catherine
Lindegger, Graham
Wilkinson, Abigail
Wassenaar, Douglas
Kerr, Philippa
Bekker, Linda-Gail
Mngadi, Kathy
Newman, Peter A.
“Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa
title “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa
title_full “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa
title_fullStr “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa
title_full_unstemmed “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa
title_short “Why Don’t You Go Into Suburbs? Why Are You Targeting Us?”: Trust and Mistrust in HIV Vaccine Trials in South Africa
title_sort “why don’t you go into suburbs? why are you targeting us?”: trust and mistrust in hiv vaccine trials in south africa
topic Research Risks, Benefits and Trust
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6238163/
https://www.ncbi.nlm.nih.gov/pubmed/30417754
http://dx.doi.org/10.1177/1556264618804740
work_keys_str_mv AT thabethesiyabonga whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT slackcatherine whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT lindeggergraham whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT wilkinsonabigail whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT wassenaardouglas whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT kerrphilippa whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT bekkerlindagail whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT mngadikathy whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica
AT newmanpetera whydontyougointosuburbswhyareyoutargetingustrustandmistrustinhivvaccinetrialsinsouthafrica